{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T13:28:09Z","timestamp":1770038889856,"version":"3.49.0"},"posted":{"date-parts":[[2023,11,13]]},"group-title":"Physiology","reference-count":62,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,11,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Friedreich\u2019s ataxia (FA) is an inherited neurodegenerative disorder that causes progressive nervous system damage resulting in impaired muscle coordination. FA is the most common autosomal recessive form of ataxia and is caused by an expansion of the DNA triplet guanine\u2013adenine\u2013adenine (GAA) in the first intron of the Frataxin gene (FXN), located on chromosome 9q13. In the unaffected population, the number of GAA repeats ranges from 6 to 27 repetitions. In FA patients, GAA repeat expansions range from 44 to 1,700 repeats which decreases frataxin protein expression. Frataxin is a mitochondrial protein essential for various cellular functions, including iron metabolism. Reduced frataxin expression is thought to negatively affect mitochondrial iron metabolism, leading to increased oxidative damage. Although FA is considered a neurodegenerative disorder, FA patients display heart disease that includes hypertrophy, heart failure, arrhythmias, conduction abnormalities, and cardiac fibrosis.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>\n                    In this work, we investigated whether abnormal Ca\n                    <jats:sup>2+<\/jats:sup>\n                    handling machinery is the molecular mechanism that perpetuates cardiac dysfunction in FA.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We used the frataxin knock-out (FXN-KO) mouse model of FA as well as human heart samples from donors with FA and from unaffected donors. ECG and echocardiography were used to assess cardiac function in the mice. Expression of calcium handling machinery proteins was assessed with proteomics and western blot. In left ventricular myocytes from FXN-KO and FXN-WT mice, the IonOptix system was used for calcium imaging, the seahorse assay was utilized to measure oxygen consumption rate (OCR), and confocal imaging was used to quantify the mitochondrial membrane potential (\u0394\u03c8m) and reactive oxygen species (ROS).<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We found that major contractile proteins, including SERCA2a and Ryr2, were downregulated in human left ventricular samples from deceased donors with FA compared to unaffected donors, similar to the downregulation of these proteins in the left ventricular tissue from FXN-KO compared to FXN-WT. On the ECG, the RR, PR, QRS, and QTc were significantly longer in the FXN-KO mice compared to FXN-WT. The ejection fraction and fractional shortening were significantly decreased and left ventricular wall thickness and diameter were significantly increased in the FXN-KO mice versus FXN-WT. The mitochondrial membrane potential \u0394\u03c8m was depolarized, ROS levels were elevated, and OCR was decreased in ventricular myocytes from FXN-KO versus FXN-WT.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The development of left ventricular contractile dysfunction in FA is associated with reduced expression of calcium handling proteins and mitochondrial dysfunction.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2023.11.09.566141","type":"posted-content","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T19:10:17Z","timestamp":1699902617000},"source":"Crossref","is-referenced-by-count":0,"title":["The Cardiac Calcium Handling Machinery is Remodeled in Friedreich\u2019s Ataxia"],"prefix":"10.64898","author":[{"given":"Roman","family":"Czornobil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Obada","family":"Abou-Assali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Remily-Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami F.","family":"Noujaim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bojjibabu","family":"Chidipi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2023111606000976000_2023.11.09.566141v1.1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073812448535"},{"key":"2023111606000976000_2023.11.09.566141v1.2","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5254.1423"},{"key":"2023111606000976000_2023.11.09.566141v1.3","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.56.10.1201"},{"key":"2023111606000976000_2023.11.09.566141v1.4","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2009.3015"},{"key":"2023111606000976000_2023.11.09.566141v1.5","first-page":"12239","article-title":"2nd","volume":"97","year":"2000","journal-title":"Lowell BB and Kahn CR. Frataxin activates mitochondrial energy conversion and oxidative phosphorylation. Proceedings of the National Academy of Sciences of the United States of America"},{"key":"2023111606000976000_2023.11.09.566141v1.6","doi-asserted-by":"publisher","DOI":"10.1126\/science.1098991"},{"key":"2023111606000976000_2023.11.09.566141v1.7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122538"},{"key":"2023111606000976000_2023.11.09.566141v1.8","doi-asserted-by":"publisher","DOI":"10.1177\/0883073812448230"},{"key":"2023111606000976000_2023.11.09.566141v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2011.05.023"},{"key":"2023111606000976000_2023.11.09.566141v1.10","doi-asserted-by":"crossref","first-page":"e0225147","DOI":"10.1371\/journal.pone.0225147","article-title":"Left ventricular structural and functional changes in Friedreich ataxia \u2013 Relationship with body size, sex, age and genetic severity","volume":"14","year":"2019","journal-title":"PloS one"},{"key":"2023111606000976000_2023.11.09.566141v1.11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1525-2167(03)00013-1","article-title":"Dilated Cardiomyopathy in Friedreich\u2019s Ataxia: 2D Echo and Tissue-Doppler Analysis of Left Ventricular and Atrial Function","volume":"4","year":"2003","journal-title":"European Journal of Echocardiography"},{"key":"2023111606000976000_2023.11.09.566141v1.12","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2021-322455"},{"key":"2023111606000976000_2023.11.09.566141v1.13","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/europace\/eur156","article-title":"An unusual atrial tachycardia in a patient with Friedreich ataxia","volume":"13","year":"2011","journal-title":"Europace : European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology"},{"key":"2023111606000976000_2023.11.09.566141v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2010.02.056"},{"key":"2023111606000976000_2023.11.09.566141v1.15","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X10666140514101748"},{"key":"2023111606000976000_2023.11.09.566141v1.16","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2015.1855","article-title":"A 22-Year Follow-up Study of Long-term Cardiac Outcome and Predictors of Survival in Friedreich Ataxia","volume":"72","year":"2015","journal-title":"JAMA Neurology"},{"key":"2023111606000976000_2023.11.09.566141v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ppedcard.2011.02.007"},{"key":"2023111606000976000_2023.11.09.566141v1.18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4330\/wjc.v11.i1.1","article-title":"Heart disease in Friedreich\u2019s ataxia","volume":"11","year":"2019","journal-title":"World J Cardiol"},{"key":"2023111606000976000_2023.11.09.566141v1.19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.301651"},{"key":"2023111606000976000_2023.11.09.566141v1.20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00204-022-03385-0","article-title":"Role of Ca(2+) in healthy and pathologic cardiac function: from normal excitation-contraction coupling to mutations that cause inherited arrhythmia","volume":"97","year":"2023","journal-title":"Arch Toxicol"},{"key":"2023111606000976000_2023.11.09.566141v1.21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.110.226845"},{"key":"2023111606000976000_2023.11.09.566141v1.22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","article-title":"Mitochondrial function as a therapeutic target in heart failure","volume":"14","year":"2017","journal-title":"Nature Reviews Cardiology"},{"key":"2023111606000976000_2023.11.09.566141v1.23","first-page":"79","article-title":"Dell\u2019Italia LJ, Wu Y, O\u2019Rourke B and Zhou L. Impaired mitochondrial network excitability in failing guinea-pig cardiomyocytes","volume":"109","year":"2015","journal-title":"Cardiovascular research"},{"key":"2023111606000976000_2023.11.09.566141v1.24","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000432861.55968.a6"},{"key":"2023111606000976000_2023.11.09.566141v1.25","doi-asserted-by":"publisher","DOI":"10.1038\/84818"},{"key":"2023111606000976000_2023.11.09.566141v1.26","doi-asserted-by":"publisher","DOI":"10.1038\/84818"},{"key":"2023111606000976000_2023.11.09.566141v1.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2017.07.009"},{"key":"2023111606000976000_2023.11.09.566141v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3495(99)77214-0"},{"key":"2023111606000976000_2023.11.09.566141v1.29","doi-asserted-by":"publisher","DOI":"10.2144\/000113610"},{"key":"2023111606000976000_2023.11.09.566141v1.30","doi-asserted-by":"crossref","unstructured":"Chalmers S and McCarron JG . The mitochondrial membrane potential and Ca<sup=2+<\/sup= oscillations in smooth muscle. Journal of Cell Science. 2008;121:75.","DOI":"10.1242\/jcs.014522"},{"key":"2023111606000976000_2023.11.09.566141v1.31","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2010.202838"},{"key":"2023111606000976000_2023.11.09.566141v1.32","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00638.2014"},{"key":"2023111606000976000_2023.11.09.566141v1.33","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvu112"},{"key":"2023111606000976000_2023.11.09.566141v1.34","doi-asserted-by":"crossref","unstructured":"Au - Tachibana S, Au - Chen C, Au - Zhang OR, Au - Schurr SV, Au - Hill C, Au - Li R, Au - Manso AM, Au - Zhang J, Au - Andreyev A, Au - Murphy AN, Au - Ross RS and Au - Cho Y. Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer. JoVE. 2019:e59052.","DOI":"10.3791\/59052-v"},{"key":"2023111606000976000_2023.11.09.566141v1.35","doi-asserted-by":"crossref","unstructured":"Dematteis G , Vydmantait\u0117 G , Ruffinatti FA , Chahin M , Farruggio S , Barberis E , Ferrari E , Marengo E , Distasi C , Mork\u016bnien\u0117 R , Genazzani AA , Grilli M , Grossini E , Corazzari M , Manfredi M , Lim D , Jekabsone A and Tapella L . Proteomic analysis links alterations of bioenergetics, mitochondria-ER interactions and proteostasis in hippocampal astrocytes from 3xTg-AD mice. Cell Death & Disease. 2020;11:645.","DOI":"10.1038\/s41419-020-02911-1"},{"key":"2023111606000976000_2023.11.09.566141v1.36","doi-asserted-by":"crossref","unstructured":"Chidipi B , Shah SI , Reiser M , Kanithi M , Garces A , Cha BJ , Ullah G and Noujaim SF . All-Trans Retinoic Acid Increases DRP1 Levels and Promotes Mitochondrial Fission. Cells. 2021;10.","DOI":"10.3390\/cells10051202"},{"key":"2023111606000976000_2023.11.09.566141v1.37","first-page":"489","article-title":"The Heart Disease of Friedreich\u2019s Ataxia: a Clinical and Electrocardiographic Study of 115 Patients, with an Analysis of Serial Electrocardiographic Changes in 30 Cases","volume":"52","year":"1983","journal-title":"QJM: An International Journal of Medicine"},{"key":"2023111606000976000_2023.11.09.566141v1.38","doi-asserted-by":"crossref","first-page":"e12813","DOI":"10.1111\/anec.12813","article-title":"Electrocardiogram in Friedreich\u2019s ataxia: A short-term surrogate endpoint for treatment efficacy","volume":"26","year":"2021","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2023111606000976000_2023.11.09.566141v1.39","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.059477"},{"key":"2023111606000976000_2023.11.09.566141v1.40","first-page":"214","article-title":"Friedreich\u2019s ataxia as a cause of premature coronary artery disease","volume":"34","year":"2007","journal-title":"Tex Heart Inst J"},{"key":"2023111606000976000_2023.11.09.566141v1.41","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(86)80159-0"},{"key":"2023111606000976000_2023.11.09.566141v1.42","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90369-X"},{"key":"2023111606000976000_2023.11.09.566141v1.43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40256-019-00375-z","article-title":"Predictors of Left Ventricular Dysfunction in Friedreich\u2019s Ataxia in a 16-Year Observational Study","volume":"20","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"key":"2023111606000976000_2023.11.09.566141v1.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.05.074"},{"key":"2023111606000976000_2023.11.09.566141v1.45","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200923030-00003"},{"key":"2023111606000976000_2023.11.09.566141v1.46","doi-asserted-by":"publisher","DOI":"10.1007\/BF00794072"},{"key":"2023111606000976000_2023.11.09.566141v1.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2012.07.005"},{"key":"2023111606000976000_2023.11.09.566141v1.48","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3510"},{"key":"2023111606000976000_2023.11.09.566141v1.49","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2217\/14796678.3.4.413","article-title":"Treatment of heart failure by calcium cycling gene therapy","volume":"3","year":"2007","journal-title":"Future cardiology"},{"key":"2023111606000976000_2023.11.09.566141v1.50","doi-asserted-by":"publisher","DOI":"10.1038\/ncpcardio1301"},{"key":"2023111606000976000_2023.11.09.566141v1.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2007.01.001"},{"key":"2023111606000976000_2023.11.09.566141v1.52","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.302187"},{"key":"2023111606000976000_2023.11.09.566141v1.53","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.114.300568"},{"key":"2023111606000976000_2023.11.09.566141v1.54","doi-asserted-by":"publisher","DOI":"10.1529\/biophysj.107.114546"},{"key":"2023111606000976000_2023.11.09.566141v1.55","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.112.268094"},{"issue":"110","key":"2023111606000976000_2023.11.09.566141v1.56","first-page":"796","article-title":"Phosphorylation in Heart Failure","volume":"2012","author":"Bers DM. Ryanodine Receptor S","year":"2808","journal-title":"Circulation research"},{"key":"2023111606000976000_2023.11.09.566141v1.57","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000093399.11734.B3"},{"key":"2023111606000976000_2023.11.09.566141v1.58","doi-asserted-by":"crossref","unstructured":"Chidipi B , Angulo MB , Shah SI , Rieser M , Ullah G , McDonald TV and Noujaim SF . The dynamin-related protein 1 is decreased and the mitochondrial network is altered in Friedreich\u2019s ataxia cardiomyopathy. Int J Biochem Cell Biol. 2022;143:106137.","DOI":"10.1016\/j.biocel.2021.106137"},{"key":"2023111606000976000_2023.11.09.566141v1.59","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.redox.2018.09.018","article-title":"Restoration of SERCA ATPase prevents oxidative stress-related muscle atrophy and weakness","volume":"20","year":"2019","journal-title":"Redox Biol"},{"key":"2023111606000976000_2023.11.09.566141v1.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2007.10.008"},{"key":"2023111606000976000_2023.11.09.566141v1.61","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000055872.50364.FC"},{"key":"2023111606000976000_2023.11.09.566141v1.62","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2006.8.438"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2023.11.09.566141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:30:48Z","timestamp":1768455048000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2023.11.09.566141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":62,"URL":"https:\/\/doi.org\/10.1101\/2023.11.09.566141","relation":{},"subject":[],"published":{"date-parts":[[2023,11,13]]},"subtype":"preprint"}}